Also from this source

27 Jun, 2018, 07:00 BST4D Presents at IHMC 2018


You just read:

4D pharma plc Enters Into Clinical Collaboration Agreement With MSD Investigating the Combination of KEYTRUDA® (pembrolizumab) and MRx0518 in Patients With Solid Tumours

News provided by

4D Pharma PLC

07 Jun, 2018, 07:00 BST